Suppr超能文献

常见的NOD2/CARD15变异与匈牙利患者散发性结直肠癌的易感性或临床病理特征无关。

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.

作者信息

Lakatos Peter Laszlo, Hitre Erika, Szalay Ferenc, Zinober Kerstin, Fuszek Peter, Lakatos Laszlo, Fischer Simon, Osztovits Janos, Gemela Orsolya, Veres Gabor, Papp Janos, Ferenci Peter

机构信息

1st Department of Medicine, Semmelweis University, Budapest, Hungary.

出版信息

BMC Cancer. 2007 Mar 27;7:54. doi: 10.1186/1471-2407-7-54.

Abstract

BACKGROUND

Epidemiological observations suggest that cancer arises from chronically inflamed tissues. Inflammatory bowel disease (IBD) is a typical example as patients with longstanding IBD are at an increased risk for developing colorectal cancer (CRC) and mutations of the NOD2/CARD15 gene increase the risk for Crohn's disease (CD). Recently, NOD2/CARD15 has been associated with a risk for CRC in some studies, which stemmed from ethnically diverse populations. Our aim was to identify common NOD2/CARD15 mutations in Hungarian patients with sporadic CRC.

METHODS

A total of 194 sporadic CRC patients (m/f: 108/86, age at diagnosis of CRC: 63.2 +/- 9.1 years old) and 200 healthy subjects were included. DNA was screened for SNP8, SNP12 and SNP13 NOD2/CARD15 mutations by denaturing-HPLC and confirmed by direct sequencing.

RESULTS

NOD2/CARD15 mutations were found in 28 patients (14.4%) and in 23 controls (11.5%, p = NS). Allele frequencies for SNP8/R702W (1.8% vs. 1.5%) SNP12/G908R (1.8% vs. 1.8%) and SNP13/3020insC (3.6% vs. 2.5%) were also not statistically different between patients and controls. The clinicopathologic characteristics of CRC patients with or without NOD2/CARD15 mutations were not significantly different.

CONCLUSION

Our results suggest that common NOD2/CARD15 mutations alone do not contribute to CRC risk in the Hungarian population.

摘要

背景

流行病学观察表明,癌症起源于慢性炎症组织。炎症性肠病(IBD)就是一个典型例子,因为长期患有IBD的患者患结直肠癌(CRC)的风险增加,而NOD2/CARD15基因突变会增加克罗恩病(CD)的风险。最近,在一些针对不同种族人群的研究中,NOD2/CARD15与CRC风险相关。我们的目的是确定匈牙利散发性CRC患者中常见的NOD2/CARD15突变。

方法

共纳入194例散发性CRC患者(男/女:108/86,CRC诊断时年龄:63.2±9.1岁)和200名健康受试者。通过变性高效液相色谱法筛查DNA中的NOD2/CARD15基因SNP8、SNP12和SNP13突变,并通过直接测序进行确认。

结果

在28例患者(14.4%)和23名对照者(11.5%,p=无统计学意义)中发现了NOD2/CARD15突变。患者和对照者之间SNP8/R702W(1.8%对1.5%)、SNP12/G908R(1.8%对1.8%)和SNP13/3020insC(3.6%对2.5%)的等位基因频率也无统计学差异。有无NOD2/CARD15突变的CRC患者的临床病理特征无显著差异。

结论

我们的结果表明,仅常见的NOD2/CARD15突变不会增加匈牙利人群患CRC的风险。

相似文献

2
4
CARD15 mutations and colorectal cancer in a South European country.
Int J Colorectal Dis. 2010 Oct;25(10):1211-9. doi: 10.1007/s00384-010-1028-0. Epub 2010 Jul 30.
5
CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis.
Respiration. 2007;74(1):76-9. doi: 10.1159/000090638. Epub 2006 Jan 2.
6
NOD2/CARD15 variants in Malaysian patients with sporadic colorectal cancer.
Genet Mol Res. 2014 Mar 19;13(3):7079-85. doi: 10.4238/2014.March.19.3.
8
NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease.
Am J Gastroenterol. 2003 Nov;98(11):2479-84. doi: 10.1111/j.1572-0241.2003.08673.x.
9
NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
Eur J Gastroenterol Hepatol. 2006 Aug;18(8):895-9. doi: 10.1097/00042737-200608000-00016.
10
Detection of mutations in gene in Arab patients with Crohn's disease.
Saudi J Gastroenterol. 2021 Jul-Aug;27(4):240-248. doi: 10.4103/sjg.sjg_582_20.

引用本文的文献

2
Low-Penetrance Susceptibility Variants in Colorectal Cancer-Current Outlook in the Field.
Int J Mol Sci. 2024 Jul 30;25(15):8338. doi: 10.3390/ijms25158338.
3
Clinicopathological characteristics of breast cancer patients with mutation according to age.
Contemp Oncol (Pozn). 2020;24(2):79-86. doi: 10.5114/wo.2020.97475. Epub 2020 Jul 3.
4
The Association between Nod2 R702w Polymorphism and Susceptibility to Colorectal Cancer in Romanian Patients.
Curr Health Sci J. 2018 Apr-Jun;44(2):135-139. doi: 10.12865/CHSJ.44.02.07. Epub 2018 Mar 27.
5
NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis.
Cell Mol Gastroenterol Hepatol. 2019;7(2):357-369. doi: 10.1016/j.jcmgh.2018.10.009. Epub 2018 Oct 23.
7
NOD2 mutations and colorectal cancer - Where do we stand?
World J Gastrointest Surg. 2016 Apr 27;8(4):284-93. doi: 10.4240/wjgs.v8.i4.284.
8
The intestinal microbiota: its role in health and disease.
Eur J Pediatr. 2015 Feb;174(2):151-67. doi: 10.1007/s00431-014-2476-2. Epub 2015 Jan 7.
9
3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer.
Med Oncol. 2014 May;31(5):954. doi: 10.1007/s12032-014-0954-z. Epub 2014 Apr 10.
10
NOD2 polymorphisms associated with cancer risk: a meta-analysis.
PLoS One. 2014 Feb 20;9(2):e89340. doi: 10.1371/journal.pone.0089340. eCollection 2014.

本文引用的文献

6
Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer.
Cancer Res. 2006 Mar 1;66(5):2532-5. doi: 10.1158/0008-5472.CAN-05-4165.
8
10
Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Science. 2005 Feb 4;307(5710):734-8. doi: 10.1126/science.1103685.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验